ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of September

September 26, 2014

Physicians Accept Plans by City of Hope to Pay for Services Through New Foundation

June 3, 2011

NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers

November 21, 1975

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

GI Intergroup called a model for proposed scientific steering committees.

June 10, 2005

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995